Royal Bank of Canada »

Actuate Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Actuate Therapeutics shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $263k 35k 7.45